GENB SCHEDULE 13G: SEC filing
A Schedule 13G was
Filed with the SEC on · accession 0000315066-26-002749
GENB filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 5, 2026. A Schedule 13G was filed regarding Generate Biomedicines, Inc. (GENB), indicating a passive ownership position by an institutional or other holder.
Summary of the filing
A Schedule 13G was filed regarding Generate Biomedicines, Inc. (GENB), indicating a passive ownership position by an institutional or other holder. The filing text provided is only a directory listing and does not disclose the holder's identity, ownership percentage, or share count.
Key details
✦ Ask GOAX AI about this filing — what it means for GENB, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for GENB?
Click hereFrequently asked questions
What did GENB file with the SEC on Nov 5, 2026?
GENB filed a SCHEDULE 13G (SEC filing). A Schedule 13G was filed regarding Generate Biomedicines, Inc. (GENB), indicating a passive ownership position by an institutional or other holder. The filing text provided is only a directory listing and does not disclose the holder's identity, ownership percentage, or share count.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
Other GENB SEC filings
Get alerts when GENB files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days